[123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset

Neuroreport. 2007 Sep 17;18(14):1499-502. doi: 10.1097/WNR.0b013e3282ef69f9.

Abstract

We performed [123I]FP-CIT/SPECT in 20 drug-naive Parkinson's disease (PD) patients, 10 with unilateral akinesia/rigidity at onset (arPD) and 10 with additional tremor-at-rest (tPD), to evaluate whether resting tremor at onset is associated with differences in striatal dopamine transporter binding. Patients of the two cohorts were matched for age, disease duration (<3 years) and severity of non-tremor motor symptoms; 31 healthy participants served as controls. Mean striatal dopamine transporter binding reduction in PD patients vs. controls was 42% for arPD and 50% for tPD; mean ipsilateral striatum and caudate nucleus uptake values were lower by 12 and 24%, respectively, in tPD than arPD. We conclude that widespread degeneration of the nigrostriatal dopaminergic pathway might be necessary for the development of parkinsonian tremor-at-rest.

MeSH terms

  • Aged
  • Corpus Striatum / diagnostic imaging*
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Iodine Radioisotopes / pharmacokinetics
  • Male
  • Middle Aged
  • Muscle Rigidity / diagnostic imaging
  • Muscle Rigidity / etiology*
  • Muscle Rigidity / pathology
  • Parkinson Disease / complications*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / pathology
  • Tomography, Emission-Computed, Single-Photon*
  • Tremor / diagnostic imaging
  • Tremor / etiology*
  • Tremor / pathology
  • Tropanes / pharmacokinetics*

Substances

  • Iodine Radioisotopes
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane